EUROIMMUN has been developing and marketing innovative immunoblot technologies for over 30 years. With broad antigen combinations and full automatability, EUROIMMUN multiplex immunoblots represent a staple of laboratory diagnostics.
The 25th International Congress of Clinical Chemistry and Laboratory Medicine (WorldLab) and 25th European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab) was hosted by the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), on the occasion of their 55th Annual congress at the new Rome Convention Center from 21-25 May 2023.
by Dr James McCracken Most of us will have some sort of knowledge or experience of flow cytometers, even if it’s just at the level of knowing that they are large instruments that have their own lab space and a dedicated team of people to run them and that they usually seem to be used […]
A near-patient approach to combat post-partum hemorrhage by Catherine Pedrosa Fibrinogen is an essential part of the blood clotting process, and rapid testing of plasma fibrinogen concentrations aids decision-making in critical care situations, notably in postpartum hemorrhage. In 2020, around 1000 women in the World Health Organization European Region died owing to complications related to […]
The use of immunoassays is widespread in clinical lab testing as these assays have inherent high specificity and high sensitivity, and are very amenable to high-throughput formats. These attributes make them particularly useful for the measurement of low concentrations of low molecular weight drugs, metabolites or biomarkers that indicate disease diagnosis or prognosis. Although there […]
Pancreatic cancer is a devastating disease, usually first diagnosed at a late stage when the opportunity for the most effective therapy has been missed, and survival rates have not improved for decades. Early detection of the disease is crucial for giving patients the chance of therapy, but, so far, the search for serum protein biomarkers […]
Gilead Sciences announces positive results from Veklury and obeldesivir trials Gilead Sciences, announced positive results from several COVID-19 clinical and real-world evidence studies presented at ECCMID. A Phase 3 clinical study demonstrated that Veklury (remdesivir) was generally well tolerated in people with moderate to severe renal impairment. Additional data includes a retrospective real-world study which […]
Axcella Therapeutics presents results from Phase 2a clinical trial of AXA1125 for treatment of Long COVID Fatigue Axcella Therapeutics – a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions – gave two oral presentations of results from the Phase 2a clinical trial of AXA1125 in the […]
Shionogi demonstrates efficacy of cefiderocol against difficult-to-treat Gram-negative bacterial infections At ECCMID 2023, Osaka, Japan-based Shionogi announced key data for cefiderocol, an innovative siderophore cephalosporin, including new real-world evidence demonstrating its efficacy against some of the most difficult-to-treat Gram-negative bacterial infections.
ELITech showcases new high throughput sample-to-result instrument for molecular diagnostics Also at ECCMID, ELITech Group unveiled the upcoming launch of a new high throughput sample-to-result instrument for molecular diagnostics.
January 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.